These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 1466118

  • 1. Superficial bladder disease: case studies and therapeutic advances.
    Soloway MS, Droller MJ, Flanigan RC, Nseyo UO.
    Urology; 1992 Dec; 40(6 Suppl):11-22. PubMed ID: 1466118
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of superficial carcinoma of the bladder.
    Paulson DF.
    Prog Clin Biol Res; 1984 Dec; 162B():193-209. PubMed ID: 6209720
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Managing superficial bladder cancer: an overview.
    Soloway MS.
    Urology; 1992 Dec; 40(6 Suppl):5-10. PubMed ID: 1466119
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of superficial transitional cell carcinoma of the bladder.
    Fleischmann J, Goldberg G.
    Semin Urol; 1993 Nov; 11(4):193-204. PubMed ID: 8290825
    [Abstract] [Full Text] [Related]

  • 7. Treatment modalities in superficial bladder cancer.
    Irwin R, Zincke H, Droller MJ, Prout GR, Soloway MS.
    Semin Urol; 1989 Feb; 7(1 Suppl 1):1-12. PubMed ID: 2499916
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intravesical Bacillus Calmette Guerin therapy in patients with superficial bladder tumor.
    Steg A, Belas M, Leleu C, Boccon-Gibod L.
    Prog Clin Biol Res; 1989 Feb; 303():375-81. PubMed ID: 2780654
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer.
    Debruyne FM, van der Meijden AP, Schreinemachers LM, Geboers AD, Franssen MP, van Leeuwen MJ, Steerenberg PA, de Jong WH, Ruitenberg EJ.
    Prog Clin Biol Res; 1988 Feb; 269():511-24. PubMed ID: 3134662
    [No Abstract] [Full Text] [Related]

  • 12. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT, Soloway MS.
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [Abstract] [Full Text] [Related]

  • 13. BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.
    Debruyne FM, van der Meijden AP, Franssen MP.
    Prog Clin Biol Res; 1989 Aug; 303():435-46. PubMed ID: 2506556
    [No Abstract] [Full Text] [Related]

  • 14. Intravesical therapy for superficial bladder cancer.
    Malkowicz SB.
    Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
    [Abstract] [Full Text] [Related]

  • 15. BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale, design, and interim analysis of the trial of the South-East Cooperative Urological Group, The Netherlands.
    Witjes WP, van der Meijden PM, Roos EP, Witjes JA, Steerenberg PA, Doesburg W, Debruyne FM.
    Prog Clin Biol Res; 1992 Nov; 378():59-67. PubMed ID: 1301587
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. BCG in carcinoma in situ and superficial bladder tumors.
    Lamm DL.
    Prog Clin Biol Res; 1988 Nov; 269():497-510. PubMed ID: 3293069
    [No Abstract] [Full Text] [Related]

  • 20. Superficial urinary bladder cancer. Results from the Finnbladder studies and a review on instillation treatments.
    Jauhiainen K, Rintala E.
    Ann Chir Gynaecol Suppl; 1993 Nov; 206():31-8. PubMed ID: 8291866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.